Stock CYTOKINETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Cytokinetics, Inc. Nasdaq

Equities

US23282W1009

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Cytokinetics, Inc.
04-26 Cytokinetics Appoints Sung Lee as CFO MT
04-26 Cytokinetics, Incorporated Appoints Sung H. Lee as Executive Vice President, Effective as of May 8, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
AQ
Cytokinetics Appoints Sung Lee as CFO
MT
Cytokinetics, Incorporated Appoints Sung H. Lee as Executive Vice President, Effective as of May 8, 2024
CI
Cytokinetics, Incorporated Announces Chief Financial Officer Changes, Effective May 8, 2024
CI
Cytokinetics to Announce First Quarter Results on May 8, 2024
AQ
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
AQ
Cytokinetics Insider Sold Shares Worth $2,422,918, According to a Recent SEC Filing
MT
Sector Update: Health Care Stocks Rise Friday Afternoon
MT
Cytokinetics Reports Positive Follow-On Data for Prospective Heart Medication; Shares Rise
MT
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session
AQ
Cytokinetics Presents Additional 48-Week Data from Forest-Hcm, the Open Label Extension Clinical Study of Aficamten, At the American College of Cardiology 73rd Annual Scientific Session
CI
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
AQ
Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
AQ
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session
AQ
Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400 - Biotechnology
CI
Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400 Health Care
CI
Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400
CI
Cytokinetics, Incorporated(NasdaqGS:CYTK) dropped from S&P 600
CI
Cytokinetics, Incorporated(NasdaqGS:CYTK) dropped from S&P 600 Health Care
CI
Transcript : Cytokinetics, Incorporated Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 09:00 AM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CYTK Stock
  4. Stock
  5. News Cytokinetics, Inc.